For research use only. Not for therapeutic Use.
Sofosbuvir 3′,5′-Bis-(S)-phosphate(Cat No.:R025911), is a metabolite of the antiviral drug Sofosbuvir. Sofosbuvir is a potent direct-acting antiviral medication used to treat chronic hepatitis C virus (HCV) infections. When administered, Sofosbuvir undergoes intracellular metabolism, leading to the formation of its active triphosphate form, Sofosbuvir 3′,5′-Bis-(S)-phosphate. This active metabolite inhibits the HCV RNA-dependent RNA polymerase, NS5B, thereby blocking viral replication and aiding in the elimination of the hepatitis C virus from the body.
Catalog Number | R025911 |
CAS Number | 1337482-17-3 |
Synonyms | (2S)-Isopropyl 2-(((((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-((((R)-(((S)-1-isopropoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)methyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)amino)propanoate |
Molecular Formula | C₃₄H₄₅FN₄O₁₃P₂ |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-4-methyl-3-[[[(2S)-1-oxo-1-propan-2-yloxypropan-2-yl]amino]-phenoxyphosphoryl]oxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
InChI | InChI=1S/C34H45FN4O13P2/c1-21(2)47-30(41)23(5)37-53(44,50-25-14-10-8-11-15-25)46-20-27-29(34(7,35)32(49-27)39-19-18-28(40)36-33(39)43)52-54(45,51-26-16-12-9-13-17-26)38-24(6)31(42)48-22(3)4/h8-19,21-24,27,29,32H,20H2,1-7H3,(H,37,44)(H,38,45)(H,36,40,43)/t23-,24-,27+,29+,32+,34+,53?,54?/m0/s1 |
InChIKey | WVORGVRHMQFKTN-ACVYKXDBSA-N |
SMILES | CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)OP(=O)(NC(C)C(=O)OC(C)C)OC3=CC=CC=C3)OC4=CC=CC=C4 |